Abstract
A novel methodology for incorporating gentamicin into macromolecular complexes with anionic homo- and block copolymers via cooperative electrostatic interactions is described. Block copolymers of poly(ethylene oxide-b-sodium acrylate) (PEO-b-PAA− +Na) or poly(ethylene oxide-b-sodium methacrylate) (PEO-b-PMA− +Na) were blended with PAA− Na+ and complexed with the polycationic antibiotic gentamicin. Gentamicin nanoplexes made with PEO-b-PMA− +Na/PAA− +Na (PMPG) and analogous nanoplexes with PEO-b-PAA− +Na/PAA− +Na (PAPG) had mean intensity average diameters of 120 and 90 nm, zeta potentials of −17 and −11 mv, and incorporated 26% and 23% by weight of gentamicin, respectively. Gentamicin release rates at physiological pH from nanoplexes were relatively slow. PAPG and PMPG as drug delivery systems for treating murine salmonellosis at doses similar to the free gentamicin experiments resulted in reduced numbers of viable bacteria in the liver and spleen. Polymeric nanoplexes developed by this methodology can potentially improve targeting of intracellular pathogens.
Similar content being viewed by others
References
Azamian BR, Coleman KS, Davis JJ, Hanson N, Green ML (2002) Directly observed covalent coupling of quantum dots to single-wall carbon nanotubes. Chem Commun (Camb) 4:366–367. doi:10.1039/b110690b
Cordeiro C, Wiseman DJ, Lutwyche P, Uh M, Evans JC, Finlay BB, Webb MS (2000) Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar typhimurium intracellular infection model. Antimicrob Agents Chemother 44:533–539. doi:10.1128/AAC.44.3.533-539.2000
Davaran S, Rashidi MR, Pourabbas B, Dadashzadeh M, Haghshenas NM (2006) Adriamycin release from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles: synthesis and in vitro characterization. Int J Nanomedicine 1:535–539. doi:10.2147/nano.2006.1.4.535
Ellbogen MH, Olsen KM, Gentry-Nielsen MJ, Preheim LC (2003) Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia. J Antimicrob Chemother 51:83–91. doi:10.1093/jac/dkg024
Galdiero F, Carratelli CR, Nuzzo I, Bentivoglio C, De Martino L, Folgore A, Galdiero M (1995) Enhanced cellular response in mice treated with a Brucella antigen-liposome mixture. FEMS Immunol Med Microbiol 10:235–243. doi:10.1111/j.1574-695X.1995.tb00038.x
Gamazo C, Lecaroz MC, Prior S, Vitas AI, Campanero MA, Irache JM, Blanco-Prieto MJ (2006) Chemical biological factors in the control of Brucellosis. Curr Drug Deliv 3:359–365. doi:10.2174/156720106778559038
Gaspar MM, Cruz A, Penha AF, Reymao J, Sousa AC, Eleuterio CV, Domingues SA, Fraga AG, Filho AL, Cruz ME, Pedrosa J (2008) Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis. Int J Antimicrob Agents 31:37–45. doi:10.1016/j.ijantimicag.2007.08.008
Gupta K, Ganguli M, Pasha S, Maiti S (2006) Nanoparticle formation from poly(acrylic acid) oppositely charged peptides. Biophys Chem 119:303–306. doi:10.1016/j.bpc.2005.09.013
Hou SCEL, Taton D, Gnanou Y (2003) Synthesis of water-soluble star-block dendrimer-like copolymers based on poly(ethylene oxide) -poly(acrylic acid). Macromolecules 36:3874–3881. doi:10.1021/ma021565d
Lecaroz C, Blanco-Prieto MJ, Burrell MA, Gamazo C (2006a) Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin. J Antimicrob Chemother 58:549–556. doi:10.1093/jac/dkl257
Lecaroz C, Campanero MA, Gamazo C, Blanco-Prieto MJ (2006b) Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method. J Antimicrob Chemother 58:557–563. doi:10.1093/jac/dkl258
Lecaroz C, Gamazo C, Blanco-Prieto MJ (2006c) Nanocarriers with gentamicin to treat intracellular pathogens. J Nanosci Nanotechnol 6:3296–3302. doi:10.1166/jnn.2006.478
Lecaroz MC, Blanco-Prieto MJ, Campanero MA, Salman H, Gamazo C (2007) Poly(DL-lactide-co-glycolide) particles containing gentamicin: pharmacokinetics, pharmacodynamics in Brucella melitensis-infected mice. Antimicrob Agents Chemother 51:1185–1190. doi:10.1128/AAC.00809-06
Lutwyche P, Cordeiro C, Wiseman DJ, St-Louis M, Uh M, Hope MJ, Webb MS, Finlay BB (1998) Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes. Antimicrob Agents Chemother 42(10):2511–2520
Monack DM, Bouley DM, Falkow S (2004) Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice can be reactivated by IFN-gamma neutralization. J Exp Med 199:231–241. doi:10.1084/jem.20031319
Oskay-Oezcelik G, Koensgen D, Hindenburg HJ, Klare P, Schmalfeldt B, Lichtenegger W, Chekerov R, Al-Batran SE, Neumann U, Sehouli J (2008) Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO. Anticancer Res 28:1329–1334
Page-Clisson ME, Pinto-Alphary H, Chachaty E, Couvreur P, Remont A (1998) Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella. Pharm Res 15:544–549. doi:10.1023/A:1011921608964
Pan J, Zhao M, Liu Y, Wang B, Mi L, Yang L (2008) Development of a new poly(ethylene glycol)-graft-poly(d,l-lactic acid) as potential drug carriers. J Biomed Mater Res A 89(A) 160–167
Pandey R, Khuller GK (2007) Nanoparticle-based oral drug delivery system for an injectable antibiotic—streptomycin. Evaluation in a murine tuberculosis model. Chemotherapy 53:437–441. doi:10.1159/000110009
Prior S, Ger B, Irache JM, Gamazo C (2005) Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. J Antimicrob Chemother 55:1032–1036. doi:10.1093/jac/dki144
Ristuccia AM, Cunha BA (1982) The aminoglycosides. Med Clin North Am 66:303–312
Rudt S, Muller RH (1993) In vitro phagocytosis assay of nano-microparticles by chemiluminescense III: Uptake of differently sized surface-modified particles, its correlation to particle properties, in vivo distribution. Eur J Pharm Sci 1:31–39. doi:10.1016/0928-0987(93)90015-3
Seleem MN, Boyle SM, Sriranganathan N (2008) Brucella: a pathogen without classic virulence genes. Vet Microbiol 129:1–14. doi:10.1016/j.vetmic.2007.11.023
Smyth Templeton N (2003) Cationic liposomes as in vivo delivery vehicles. Curr Med Chem 10:1279–1287. doi:10.2174/0929867033457421
Steinberg BE, Grinstein S (2008) Pathogen destruction versus intracellular survival: the role of lipids as phagosomal fate determinants. J Clin Invest 118:2002–2011. doi:10.1172/JCI35433
Sukupolvi S, Edelstein A, Rhen M, Normark SJ, Pfeifer JD (1997) Development of a murine model of chronic Salmonella infection. Infect Immun 65:838–842
Vonarbourg A, Passirani C, Saulnier P, Benoit JP (2006) Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27:4356–4373. doi:10.1016/j.biomaterials.2006.03.039
Yang T, Cui FD, Choi MK, Cho JW, Chung SJ, Shim CK, Kim DD (2007a) Enhanced solubility-stability of PEGylated liposomal paclitaxel: in vitro–in vivo evaluation. Int J Pharm 338:317–326. doi:10.1016/j.ijpharm.2007.02.011
Yang T, Cui FD, Choi MK, Lin H, Chung SJ, Shim CK, Kim DD (2007b) Liposome formulation of paclitaxel with enhanced solubility and stability. Drug Deliv 14:301–308. doi:10.1080/10717540601098799
Acknowledgments
The authors are grateful to NSF DMR-0312046 and to Virginia Tech’s Institute for Critical Technologies and Applied Sciences (ICTAS) for funding.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ranjan, A., Pothayee, N., Seleem, M. et al. Drug delivery using novel nanoplexes against a Salmonella mouse infection model. J Nanopart Res 12, 905–914 (2010). https://doi.org/10.1007/s11051-009-9641-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11051-009-9641-y